| 23rd week of 2016 patent applcation highlights part 8 |
| Patent application number | Title | Published |
| 20160158114 | Disposable Emesis Bag with Comfort Features | 2016-06-09 |
| 20160158115 | Color Cosmetic with High Coverage and Naturalness | 2016-06-09 |
| 20160158116 | WRINKLE REDUCING SKIN PATCH, PROCESS OF MANUFACTURE AND USEFUL ARTICLES THEREOF | 2016-06-09 |
| 20160158117 | LONG LASTING BREATH MINT | 2016-06-09 |
| 20160158118 | OIL/OIL EMULSIONS CONTAINING PARTICLES WITH A BREAKAGE OF CURVATURE, COMPOSITIONS COMPRISING THEM AND USE OF THE PARTICLES FOR STABILIZING O/O EMULSIONS | 2016-06-09 |
| 20160158119 | PERSONALIZING SUBSTANCE FOR APPLICATION TO THE SKIN OR ADDITION TO TATTOO INK AND METHODS OF PREPARATION THEREOF | 2016-06-09 |
| 20160158120 | PERSONALIZING SUBSTANCE FOR APPLICATION TO THE SKIN OR ADDITION TO TATTOO INK AND METHODS OF PREPARATION THEREOF | 2016-06-09 |
| 20160158121 | POLYUREA CAPSULE COMPOSITIONS | 2016-06-09 |
| 20160158122 | Microbicidal Personal Care Compositions Comprising Metal Ions | 2016-06-09 |
| 20160158123 | KIT FOR WHITENING A BODY SURFACE OF A USER, RELATED METHOD AND PROCESS | 2016-06-09 |
| 20160158124 | Beauty Care Product | 2016-06-09 |
| 20160158125 | PRODUCTS FOR OXIDATIVELY CHANGING THE COLOR OF KERATIN FIBERS, IN A DISPENSER | 2016-06-09 |
| 20160158126 | BLEACHING AGENT CONTAINING FATTY ALCOHOLS | 2016-06-09 |
| 20160158127 | SKIN-CARE OIL | 2016-06-09 |
| 20160158128 | COMPOSITION FOR HAIR FRIZZ REDUCTION | 2016-06-09 |
| 20160158129 | PRODUCTS FOR OXIDATIVE COLOUR CHANGE OF KERATINOUS FIBRES IN A DISPENSER | 2016-06-09 |
| 20160158130 | HAIR DYE COMPOSITION | 2016-06-09 |
| 20160158131 | Compositions and Methods for Stimulating Collagen Synthesis in the Skin | 2016-06-09 |
| 20160158132 | Stabilization of Cosmetic Compositions | 2016-06-09 |
| 20160158133 | PRIMECOAT COMPOSITIONS FOR PROTEINACEOUS SUBSTRATES AND METHODS OF PRIMING PROTEINACEOUS SUBSTRATES THEREWITH | 2016-06-09 |
| 20160158134 | Stable Vitamin C System | 2016-06-09 |
| 20160158135 | COMPOSITION FOR HAIR FRIZZ REDUCTION | 2016-06-09 |
| 20160158136 | COMPOSITION FOR REDUCTION OF TRPA1 AND TRPV1 SENSATIONS | 2016-06-09 |
| 20160158137 | HAIR TREATMENT SYSTEMS AND METHODS USING PEPTIDES AND OTHER COMPOSITIONS | 2016-06-09 |
| 20160158138 | KERATIN-BASED HAIR STRAIGHTENING FORMULATIONS, METHODS AND SYSTEMS | 2016-06-09 |
| 20160158139 | Compositions Comprising A Sirt6 Activator And A DNA Repair Enzyme | 2016-06-09 |
| 20160158140 | CROSS-LINKED HYALURONIC ACID, PROCESS FOR THE PREPARATION THEREOF AND USE THEREOF IN THE AESTHETIC FIELD | 2016-06-09 |
| 20160158141 | FOAMING BLEACH-BLONDING COMPOSITIONS | 2016-06-09 |
| 20160158142 | BLEACHING AGENT CONTAINING POLYMERS | 2016-06-09 |
| 20160158143 | COSMETIC COMPOSITIONS | 2016-06-09 |
| 20160158144 | COSMETIC COMPOSITIONS | 2016-06-09 |
| 20160158145 | Container | 2016-06-09 |
| 20160158146 | OCULAR THERAPEUTIC AGENT DELIVERY DEVICES AND METHODS FOR MAKING AND USING SUCH DEVICES | 2016-06-09 |
| 20160158147 | COMPOSITION AND METHOD FOR ORALLY ADMINISTERING ONE OR MORE ACTIVE AGENTS TO A PET | 2016-06-09 |
| 20160158148 | METHOD FOR TREATING A PERIODONTAL DISEASE | 2016-06-09 |
| 20160158149 | Inhalable Pharmaceutical Compositions and the Inhaler Devices Containing Them | 2016-06-09 |
| 20160158150 | Manufacture of Pharmaceutical Compositions | 2016-06-09 |
| 20160158151 | ON DEMAND VESICLE FORMATION FROM VESICLE PRECURSORS SUITABLE FOR LONG-TERM STORAGE | 2016-06-09 |
| 20160158152 | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF DIMINUTION OF BONE TISSUE | 2016-06-09 |
| 20160158153 | MULTICOMPARTMENTAL LIPID NANOPARTICLES | 2016-06-09 |
| 20160158154 | PROTEIN VESICLES AND METHODS OF MAKING AND USING THEREOF | 2016-06-09 |
| 20160158155 | MAGNETIC NANOPARTICLES USEFUL FOR MAGNETIC SENSOR DETECTION ESPECIALLY IN BIOSENSOR APPLICATIONS | 2016-06-09 |
| 20160158156 | HEAT-STABLE DRY POWDER PHARMACEUTICAL COMPOSITIONS AND METHODS | 2016-06-09 |
| 20160158157 | ANTI-TUBERCULOSIS STABLE PHARMACEUTICAL COMPOSITION IN A FORM OF A COATED TABLET COMPRISING GRANULES OF ISONIAZID AND GRANULES OF RIFAPENTINE AND ITS PROCESS OF PREPARATION | 2016-06-09 |
| 20160158158 | Encased Tamper Resistant Controlled Release Dosage Forms | 2016-06-09 |
| 20160158159 | PHARMACEUTICAL COMPOSITIONS AND RELATED METHODS OF DELIVERY | 2016-06-09 |
| 20160158160 | NANOFIBROUS MATERIALS AS DRUG, PROTEIN, OR GENETIC RELEASE VEHICLES | 2016-06-09 |
| 20160158161 | PLASTER CONTAINING FENTANYL | 2016-06-09 |
| 20160158162 | PHARMACEUTICAL COMPOSITIONS COMPRISING MONOTERPENES | 2016-06-09 |
| 20160158163 | Method For Treating Gefitinib-Resistant Non-Small-Cell Lung Cancer | 2016-06-09 |
| 20160158164 | PTEROSTILBENE (PTER) FOR USE IN THE PREVENTION AND/OR TREATMENT OF SKIN DISEASES, DAMAGES OR INJURIES | 2016-06-09 |
| 20160158165 | Combination Therapies for the Treatment of Alzheimer's Disease and Related Disorders | 2016-06-09 |
| 20160158166 | METHODS OF REDUCING BRAIN CELL APOPTOSIS | 2016-06-09 |
| 20160158167 | THERAPEUTIC AGENTS FOR USE IN THE PROPYLAXIS AND/OR TREATMENT OF HYPERKINETIC MOVEMENT DISORDERS | 2016-06-09 |
| 20160158168 | METHODS FOR THE BIOSYNTHESIS OF TAURINE OR HYPOTAURINE IN CELLS | 2016-06-09 |
| 20160158169 | Antimicrobial Compositions with Cysteamine | 2016-06-09 |
| 20160158170 | Delayed Release Cysteamine Bead Formulation, And Methods Of Making And Using Same | 2016-06-09 |
| 20160158171 | METHOD FOR TREATING INFLAMMATION AND PAIN | 2016-06-09 |
| 20160158172 | PYRAZOLOPYRIDAZINES AND METHODS FOR TREATING RETINAL-DEGENERATIVE DISEASES AND HEARING LOSS ASSOCIATED WITH USHER SYNDROME | 2016-06-09 |
| 20160158173 | METHODS FOR TREATING BRAIN INJURY | 2016-06-09 |
| 20160158174 | Enteric-Coated Functional Food Ingredients And Methods For Making The Enteric-Coated Functional Food Ingredients | 2016-06-09 |
| 20160158175 | CITRATE RESORPTION OF BONE AS A TREATMENT FOR SPINAL STENOSIS | 2016-06-09 |
| 20160158177 | NUTRITIONAL COMPOSITION FOR IMPROVING BRAIN FUNCTION IN PHENYLKETONURIA | 2016-06-09 |
| 20160158178 | DOSAGE FORMS AND THERAPEUTIC USES L-4-CHLOROKYNURENINE | 2016-06-09 |
| 20160158179 | NANOEMULSION THERAPEUTIC COMPOSITIONS AND METHODS OF USING THE SAME | 2016-06-09 |
| 20160158180 | Use of Derivatives of Polyunsaturated Fatty Acids as Medicaments | 2016-06-09 |
| 20160158181 | Use of Derivatives of Polyunsaturated Fatty Acids as Medicaments | 2016-06-09 |
| 20160158182 | OPHTHALMIC COMPOSITIONS CONTAINING A NITRIC OXIDE DONOR | 2016-06-09 |
| 20160158183 | COMPOSITIONS AND METHODS COMPRISING MEDIUM CHAIN TRIGLYCERIDES FOR TREATMENT OF EPILEPSY | 2016-06-09 |
| 20160158184 | SELF-EMULSIFYING COMPOSITION OF OMEGA3 FATTY ACID | 2016-06-09 |
| 20160158185 | SARMS AND METHOD OF USE THEREOF | 2016-06-09 |
| 20160158186 | USE OF DIANHYDROGALACTITOL AND ANALOGS AND DERIVATIVES THEREOF TO TREAT RECURRENT MALIGNANT GLIOMA OR PROGRESSIVE SECONDARY BRAIN TUMOR | 2016-06-09 |
| 20160158187 | TIGLIEN-3-ONE DERIVATIVES | 2016-06-09 |
| 20160158188 | NOVEL USE FOR PAI-1 INHIBITOR | 2016-06-09 |
| 20160158189 | SENSITIZATION OF CANCER CELLS TO APOPTOSIS INDUCTION BY FLAVAGLINES AND 5-HYDROXY-FLAVONES | 2016-06-09 |
| 20160158190 | Methods and Compositions for Inhibition of ATR and FANCD2 Activation | 2016-06-09 |
| 20160158191 | Combination Therapies for the Treatment of Alzheimer's Disease and Related Disorders | 2016-06-09 |
| 20160158192 | Combination Therapies for the Treatment of Alzheimer's Disease and Related Disorders | 2016-06-09 |
| 20160158193 | ADJUVANTS IN ANTI-CANCER CHEMOTHERAPY | 2016-06-09 |
| 20160158194 | Methods and Treatments for the Learning and Memory Deficits Associated with Noonan Syndrome | 2016-06-09 |
| 20160158195 | REDUCTION OF EPILEPTIC SEIZURES | 2016-06-09 |
| 20160158196 | A MODIFIED-RELEASE ORAL PHARMACEUTICAL FORMULATION CONTAINING GLICLAZIDE | 2016-06-09 |
| 20160158197 | Novel 1-Aryl-3-Azabicyclo[3.1.0]Hexanes: Preparation And Use To Treat Neuropsychiatric Disorders | 2016-06-09 |
| 20160158198 | COMPOSITIONS AND METHODS FOR AMELIORATING CACHEXIA | 2016-06-09 |
| 20160158199 | METHOD OF ACTIVATING REGULATORY T CELLS WITH ALPHA-2B ADRENERGIC RECEPTOR AGONISTS | 2016-06-09 |
| 20160158200 | Combinations of Hepatitis C Virus Inhibitors | 2016-06-09 |
| 20160158201 | CHEMICAL COMPOUNDS | 2016-06-09 |
| 20160158202 | Low Dose Pharmaceutical Composition | 2016-06-09 |
| 20160158203 | METHODS OF TREATMENT WITH BIOAVAILABLE COMPOSITIONS OF METAXALONE COMPRISING NONVOLATILE LIQUIDS | 2016-06-09 |
| 20160158204 | PHARMACOLOGICAL STIMULATION TO FACILITATE AND RESTORE STANDING AND WALKING FUNCTIONS IN SPINAL CORD MOTOR DISORDERS | 2016-06-09 |
| 20160158205 | COMPOSITIONS AND METHODS FOR TREATING CONDITIONS RELATED TO ELEVATED LEVELS OF EOSINOPHILS AND/OR BASOPHILS | 2016-06-09 |
| 20160158206 | Reversing Intestinal Inflammation by Inhibiting Retinoic Acid Metabolism | 2016-06-09 |
| 20160158207 | THERAPEUTIC COMPOUNDS AND USES THEREOF | 2016-06-09 |
| 20160158208 | METHODS OF USE OF CYCLOPAMINE ANALOGS | 2016-06-09 |
| 20160158209 | Compounds for Treatment of Alzheimer's Disease | 2016-06-09 |
| 20160158210 | CORNEAL ENDOTHELIUM ECM THERAPEUTIC MEDICAMENTS | 2016-06-09 |
| 20160158211 | Dosage and Use of an A2A Antagonist | 2016-06-09 |
| 20160158212 | EXTENDED RELEASE AQUEOUS SUSPENSION OF METHYLPHENIDATE OR SALTS THEREOF | 2016-06-09 |
| 20160158213 | USE OF FLECAINIDE AS AN ANTI-CONNEXIN AGENT AND METHOD FOR POTENTIATING THE EFFECTS OF A PSYCHOTROPIC DRUG | 2016-06-09 |
| 20160158214 | HEPATITIS B ANTIVIRAL AGENTS | 2016-06-09 |